Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion. When adjusted for foreign exchange impacts, revenues grew 6%. GAAP net loss attributable to Bristol Myers Squibb was $11.9 billion, or $5.89 per share, compared to net earnings of $2.3 billion, or $1.07 per share, […]
“Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion. When adjusted for foreign exchange impacts, revenues grew 6%. GAAP net loss attributable to Bristol Myers Squibb was $11.9 billion, or $5.89 per share, compared to net earnings of $2.3 billion, or $1.07 per share, […]
· April 25, 2024
Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today.
Total revenues increased 5% year-over-year to $11.9 billion. When adjusted for foreign exchange impacts, revenues grew 6%.
GAAP net loss attributable to Bristol Myers Squibb was $11.9 billion, or $5.89 per share, compared to net earnings of $2.3 billion, or $1.07 per share, last year. Adjusted net loss was $4.40 per share.
For the full year of 2024, the company expects total revenues to increase in the low single digits. Adjusted EPS is expected to range between $0.40-0.70.
